Director's Message

Dear Friend,

This year, significant advances in research and medicine have been made at Mount Sinai. From a new program for Diagnostic and Preventive Medicine to innovative research projects that encompass teams of distinguished scientists and cardiologists from here and around the world, we are steadily improving the prognosis for people living with cardiovascular disease.

Our dual mission is to integrate Mount Sinai’s resources for better care and to focus on prevention and diagnosis in cardiovascular health through research and clinical programs. Clinically, our angioplasty outcomes remain at the forefront of all major hospitals in New York City, according to the New York State Department of Health. We have, nevertheless, made two important enhancements to our Cardiac Catheterization Laboratory to take patient safety and quality of care to an even higher level. By extending the hours of operation in the laboratory to 24 hours a day, seven days a week, we are available for emergency interventions around the clock providing state-of-the-art services at all times to our cardiac patients.

Cardiovascular research continues to flourish at Mount Sinai. I will be leading a new $25 million NIH study to determine the best ways to manage and treat patients with diabetes who are known to be at high risk for developing cardiovascular disease. The FREEDOM trial, as it is called, will bring together a broad coalition of national and international academic medical centers. Our scientists continue to move forward in their exploration and refinement of MRI and CT technology, investigating the possibility of combining both machines into a single piece of equipment.

Our generous and compassionate donors, who infuse our efforts to eradicate the nation’s number one killer, made these advances possible. Philanthropy is the lifeblood that has nourished our growth into a world-class cardiovascular care center. This annual summary of philanthropic support recognizes the individuals and organizations whose contributions paved the way for groundbreaking achievements within the Zena and Michael A. Wiener Cardiovascular Institute and the Marie- Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai.

I offer my heartfelt gratitude to all of those listed here for their visionary philanthropic spirit. Their collective generosity moves us closer to the goal of making Mount Sinai the number one cardiovascular center in the world – unsurpassed in patient care, clinical research, education, and training.

Valentin Fuster, M.D., Ph.D.